TGTX - ティ―ジ―・セラピュ―ティクス (TG Therapeutics Inc.)

TGTXのニュース

   Hot Stock to Observe: TG Therapeutics, Inc. (NASDAQ:TGTX), Oragenics, Inc. (AMEX:OGEN)  2021/07/07 00:15:19 Stock Equity
TG Therapeutics, Inc. (TGTX) with the stream of -2.92% also noticed, India Oragenics, Inc. (OGEN) encountered a rapid change of -1.76% in the last hour of Tuesdays trading session. TG The post Hot Stock to Observe: TG Therapeutics, Inc. (NASDAQ:TGTX), Oragenics, Inc. (AMEX:OGEN) appeared first on Stocks Equity .
   Stock on the Move: Dave & Busters Entertainment, Inc. (NASDAQ:PLAY), TG Therapeutics, Inc. (NASDAQ:TGTX)  2021/06/28 23:27:09 Stock Equity
Dave & Busters Entertainment, Inc. (NASDAQ:PLAY) with the stream of -2.21% also noticed, India TG Therapeutics, Inc. (NASDAQ:TGTX) encountered a rapid change of -1.12% in the last hour of MONDAYs The post Stock on the Move: Dave & Busters Entertainment, Inc. (NASDAQ:PLAY), TG Therapeutics, Inc. (NASDAQ:TGTX) appeared first on Stocks Equity .
   Up to Date Stock in Review: TG Therapeutics, Inc. (NASDAQ:TGTX), AgEagle Aerial Systems, Inc. (AMEX:UAVS)  2021/06/27 23:39:13 Stock Equity
TG Therapeutics, Inc. (TGTX) with the stream of 2.78% also noticed, India AgEagle Aerial Systems, Inc. (UAVS) encountered a rapid change of 0.19% in the last hour of trading session. The post Up to Date Stock in Review: TG Therapeutics, Inc. (NASDAQ:TGTX), AgEagle Aerial Systems, Inc. (AMEX:UAVS) appeared first on Stocks Equity .
   Stock Views And Recommendations: TG Therapeutics, Inc. (NASDAQ:TGTX), Senseonics Holdings, Inc. (AMEX:SENS)  2021/06/23 22:24:37 Stock Equity
TG Therapeutics, Inc. (TGTX) with the stream of 0.59% also noticed, India Senseonics Holdings, Inc. (SENS) encountered a rapid change of 1.58% in the last hour of Wednesdays trading session. The post Stock Views And Recommendations: TG Therapeutics, Inc. (NASDAQ:TGTX), Senseonics Holdings, Inc. (AMEX:SENS) appeared first on Stocks Equity .
   Looking Into TG Therapeutics''s Return On Capital Employed  2021/06/23 14:48:30 Benzinga
During Q1, TG Therapeutics ''s (NASDAQ: TGTX ) reported sales totaled $793.00 thousand. Despite a 2.07% in earnings, the company posted a loss of $88.73 million. In Q4, TG Therapeutics brought in $38.00 thousand in sales but lost $86.93 million in earnings. What Is ROCE? Changes in earnings and sales indicate shifts in TG Therapeutics''s Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and Full story available on Benzinga.com
   H.C. Wainwright Stick to Their Buy Rating for TG Therapeutics By Investing.com  2021/02/08 16:15:01 Investing.com
H.C. Wainwright Stick to Their Buy Rating for TG Therapeutics
   UKONIQ™ (umbralisib) Now Approved by the FDA; Onco360® Selected as Exclusive Specialty Pharmacy Partner  2021/02/08 16:00:00 Business Wire
LOUISVILLE, Ky.--(BUSINESS WIRE)--Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by TG Therapeutics, Inc. to be the exclusive specialty pharmacy partner for UKONIQTM (umbralisib), a new oral treatment for adult patients with relapsed refractory marginal zone lymphoma who have received at least one prior anti-CD20-based regimen and relapsed refractory follicular lymphoma who have received at least three prior lines of systemic therapy. These indications are appro
   HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $78  2021/01/19 06:22:00 Benzinga
This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of …
   B.Riley Financial Stick to Their Buy Rating for TG Therapeutics By Investing.com  2021/01/07 09:04:20 Investing.com
B.Riley Financial Stick to Their Buy Rating for TG Therapeutics
   Real Retirement Secrets: Your Most Important Investments! - BioSci Capital Partners  2020/12/31 02:32:16 Seeking Alpha
I feature a lot of big winners over the years inside IBI. Some of our big winners include TG Therapeutics (TGTX), CRISPR Therapeutics (CRSP), CryoPort (CYRX), Intra-Cellular Therapies (ITCI), Axsome Therapeutics (AXSM), Iovance Biotherapeutics (IOVA), Corium International (CORI), Kite Pharma(KITE), Juno Therapeutics (JUNO), Sparks Therapeutics (ONCE), Tesaro(TSRO), Mirati Therapeutics (MRTX), etc …
   HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $78  2021/01/19 06:22:00 Benzinga
This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of …
   B.Riley Financial Stick to Their Buy Rating for TG Therapeutics By Investing.com  2021/01/07 09:04:20 Investing.com
B.Riley Financial Stick to Their Buy Rating for TG Therapeutics
   Real Retirement Secrets: Your Most Important Investments! - BioSci Capital Partners  2020/12/31 02:32:16 Seeking Alpha
I feature a lot of big winners over the years inside IBI. Some of our big winners include TG Therapeutics (TGTX), CRISPR Therapeutics (CRSP), CryoPort (CYRX), Intra-Cellular Therapies (ITCI), Axsome Therapeutics (AXSM), Iovance Biotherapeutics (IOVA), Corium International (CORI), Kite Pharma(KITE), Juno Therapeutics (JUNO), Sparks Therapeutics (ONCE), Tesaro(TSRO), Mirati Therapeutics (MRTX), etc …
   IBI Blogs On Retirement Secrets: Three Cardinal Sins Deterring Your Luxurious Retirement - BioSci Capital Partners  2020/12/28 00:47:06 Seeking Alpha
Some of our big winners include TG Therapeutics (TGTX), CRISPR Therapeutics (CRSP), CryoPort (CYRX), Intra-Cellular Therapies (ITCI), Axsome Therapeutics (AXSM), Corium International (CORI), Kite Pharma(KITE), Juno Therapeutics (JUNO), Sparks Therapeutics (ONCE), Tesaro(TSRO), Mirati Therapeutics (MRTX), Iovance Biotherapeutics (IOVA), Mirati Therapeutics (MRTX), etc …
   JPMorgan says stocks are primed for sustained gains in a way they haven't been in years — and identifies 43 names to buy for above-average earnings growth in 2021  2020/12/17 13:15:00 Business Insider
Summary List Placement Despite the economic carnage caused by the worldwide COVID-19 outbreak, US stock indices have soared to all-time highs. That's mostly thanks to mega-cap tech firms, which have seen astonishing appreciation as work, school, and shopping have moved largely online. Now that vaccine rollouts have begun, the stay-at-home environment that boosted these growth stocks will start to change. Still, JPMorgan equity strategists — and their peers at other firms — expect the broader market to rise in 2021. The bank anticipates an up to 19% rally in the S&P 500 that's led mostly by cyclical and value stocks. But this doesn't mean stocks with rapid earnings growth will all suffer; for one, there are many whose valuations haven't skyrocketed like the tech firms at the top of the market. If the path ahead for the economic recovery becomes clearer, some growth stocks — in addition to recovery plays — will see the momentum needed to fuel their path upward. "The equity market is facing one of the best backdrops for sustained gains in years," Dubravko Lakos-Bujas, JPMorgan's chief US equity strategist, said in a recent note. "After a prolonged period of elevated risks (global trade war, COVID-19 pandemic, US election uncertainty, etc.), the outlook is significantly clearing up, especially with news of a highly effective COVID-19 vaccine. "Corporate earnings and labor market recovery continue to come in ahead of expectations," Dubravko continued.

calendar